DK1051495T3 - Rekombinate mistelten-lectiner - Google Patents

Rekombinate mistelten-lectiner

Info

Publication number
DK1051495T3
DK1051495T3 DK99910186T DK99910186T DK1051495T3 DK 1051495 T3 DK1051495 T3 DK 1051495T3 DK 99910186 T DK99910186 T DK 99910186T DK 99910186 T DK99910186 T DK 99910186T DK 1051495 T3 DK1051495 T3 DK 1051495T3
Authority
DK
Denmark
Prior art keywords
mistletoe lectin
polypeptides
recombinant mistletoe
mistletoe lectins
pharmaceutical compositions
Prior art date
Application number
DK99910186T
Other languages
Danish (da)
English (en)
Inventor
Peter Morris
Thomas Stiefel
Wolfgang Voelter
Peter Welters
Original Assignee
Biosyn Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7856511&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1051495(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biosyn Arzneimittel Gmbh filed Critical Biosyn Arzneimittel Gmbh
Application granted granted Critical
Publication of DK1051495T3 publication Critical patent/DK1051495T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Filtering Materials (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Seasonings (AREA)
DK99910186T 1998-02-03 1999-02-03 Rekombinate mistelten-lectiner DK1051495T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19804210A DE19804210A1 (de) 1998-02-03 1998-02-03 Rekombinante Mistellektine

Publications (1)

Publication Number Publication Date
DK1051495T3 true DK1051495T3 (da) 2006-05-22

Family

ID=7856511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99910186T DK1051495T3 (da) 1998-02-03 1999-02-03 Rekombinate mistelten-lectiner

Country Status (8)

Country Link
US (2) US6927207B1 (fr)
EP (1) EP1051495B1 (fr)
AT (1) ATE316575T1 (fr)
CA (1) CA2320430C (fr)
DE (2) DE19804210A1 (fr)
DK (1) DK1051495T3 (fr)
ES (1) ES2257039T3 (fr)
WO (1) WO1999040109A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010011330A (ko) * 1999-07-27 2001-02-15 김종배 한국산 겨우살이 추출물과 이로부터 분리한 단백질 및 상기 단백질에서 분리한 렉틴
DE10044027A1 (de) * 2000-09-06 2002-03-14 Viscum Ag Rekombinant erzeugtes Mistellektin (ML III)
DE60220068T2 (de) 2001-07-09 2008-01-24 University Of Copenhagen Verfahren und ableger für die massenvermehrung von pflanzenparasiten
DE102011003478A1 (de) * 2011-02-01 2012-08-02 Cytavis Biopharma Gmbh Antivirales Mittel enthaltend rekombinante Mistellektine
EP2508195A1 (fr) 2011-04-06 2012-10-10 Cytavis BioPharma GmbH Médicament comprenant des lectines de gui recombinantes pour le traitement du mélanome malin
DK2723374T3 (da) * 2011-06-27 2017-11-20 Melema Pharma Gmbh Rekombinant mistelten-lektin og dettes anvendelse som adjuvans
EP3205348A1 (fr) 2016-02-15 2017-08-16 Melema Pharma GmbH Medicament comprenant des lectines de gui recombinantes pour le traitement de tumeurs au cerveau

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091309A (en) * 1986-01-16 1992-02-25 Washington University Sindbis virus vectors
EP0805686A1 (fr) * 1995-01-10 1997-11-12 Fibrogen, Inc. Methodes et formulations a base de collagene pour le traitement de maladies d'origine immunologique
EP0884388A1 (fr) * 1995-06-26 1998-12-16 MADAUS AG Köln Plantes transgéniques contenant une lectine recombinante du gui
GB9513110D0 (en) 1995-06-28 1995-08-30 Laporte Esd Ltd Dairy system cleaning preparation and method
DE19880004D2 (de) * 1997-01-02 2000-06-15 B R A I N Biotechnology Resear Rekombinante Fusionsproteine auf der Basis Ribosomen-inaktivierender Proteine der Mistel Viscum album

Also Published As

Publication number Publication date
US20050142183A1 (en) 2005-06-30
WO1999040109A2 (fr) 1999-08-12
CA2320430A1 (fr) 1999-08-12
DE19804210A1 (de) 1999-08-12
EP1051495A2 (fr) 2000-11-15
DE59913079D1 (de) 2006-04-13
US6927207B1 (en) 2005-08-09
ES2257039T3 (es) 2006-07-16
EP1051495B1 (fr) 2006-01-25
CA2320430C (fr) 2008-03-18
US7265217B2 (en) 2007-09-04
WO1999040109A3 (fr) 1999-10-07
ATE316575T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
DE69833670D1 (de) Homologe des tie-rezeptortyrosinekinase liganden
DE60134786D1 (de) Mini-dystrophin nukleinsäure- und peptidsequenzen
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
BR0316435A (pt) Produtos genéticos expressos diferencialmente em tumores e uso dos mesmos
ATE301195T1 (de) Acpl dna und polypeptide
DE60139072D1 (de) Masp-2, ein komplement fixierendes enzym, und dessen verwendungen
MY120693A (en) Human bikunin
EP1067182A3 (fr) Proteine secretoire ou proteine de membrane
DK1265914T3 (da) WNT-1-relaterede polypeptider og nukleinsyrer, der koder for samme
ATE323770T1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
WO2004024750A3 (fr) Ligands liant cd44
WO2003030821A3 (fr) Proteines de fusion d'albumine
DK1051495T3 (da) Rekombinate mistelten-lectiner
AU2003287115A1 (en) Fluorescent proteins from copepoda species and methods for using same
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
WO1998011238A3 (fr) Protease m, une nouvelle serine protease
WO2002008257A3 (fr) Nouveaux siglecs et leurs utilisations
WO2003010184A3 (fr) Motif conserve d'interaction de xiap dans la caspase-9 et la proteine smac/diablo pour moduler l'apoptose
DK1212417T3 (da) Fremmelse eller inhibering af angiogenese og vaskularisering
ATE382089T1 (de) Verfahren zum herstellen eines rekombinanten proteins
WO1999041388A3 (fr) Metalloprotease-desintegrines, adn svph3-13 et svph3-17 et polypeptides
WO2003070768A3 (fr) Variants d'epissage cd40, compositions de fabrication et procedes d'utilisation de ceux-ci
WO2002002771A3 (fr) Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier
IL143361A0 (en) IL-1 ZETA, IL-1 ZETA SPLICE VARIANTS AND XREC2 DNAs AND POLYPEPTIDES
WO2000046391A3 (fr) Genes affichant une expression amelioree pendant une senescence cellulaire et une differentiation cellulaire terminale, et leurs utilisations